Abstract
We present a 28-year-old primigravida woman in whom congestive heart failure developed 3 months after delivery of a neonate. The patient underwent doxorubicin treatment 10 years previously. The combined cardiotoxicity of prior doxorubicin treatment and pregnancy is considered, and the importance of careful follow-up of cardiac function during pregnancy and postpartum in patients previously treated with doxorubicin is stressed.
| Original language | English |
|---|---|
| Pages (from-to) | 399-400 |
| Number of pages | 2 |
| Journal | American Journal of the Medical Sciences |
| Volume | 314 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 1997 |
| Externally published | Yes |
Keywords
- Congestive heart failure
- Delivery
- Doxorubicin